In late April, Evernorth announced that its health plan Cigna and pharmacy benefit manager (PBM) Express Scripts would add coverage June 1 for the adalimumab biosimilars Cyltezo® by Boehringer Ingelheim and Simlandi® by Alvotech/Teva. On August 23, Evernorth took things a step further, announcing that it will exclude Humira® from its largest commercial formularies for … Continue reading Express Scripts Becomes Second PBM to Exclude Humira From Specific Drug Formularies